MHDIDAL

MHDIDAL 1...AMOPATOrite Et 5151 CORPORATE WAY JUPITER, FL. 33458-3101 (866)720-8386 Client: BRUCE MOSKOWITZ, M.D. 1411 N. PLAGLER DR. SUITE 7100 WEST PALM BEACH, FL 33401 Phys: MOSKOWITZ, BRUCE 2622 Patient EPSTEIN, JEFFREY Room,/ Phone: ID#: 262219530120MJE Route#: 0 DOB. 01/20/1953 Age:63 Sex:M Fasting: N Page:1 Acc# 001081881 Chart# 19530120MIE First reported on: Test Name Coll. Date: 03/28/16 Coll. Time: 00:00 AM 03/28/16 Recv. Date: 03/28/16 Print Date: 03/30/16 Recv. Time:16:54:03 Print Time: 07:40 Final report date: 03/29/16 Results Normal Range I Units Report Status: FINAL COMMENTS: COMPLETE BLOOD COUNT WHITE BLOOD CELL 3.1 L 3.9 - 11.1 K/ul Slide made RED BLOOD CELL 5.18 4.2 - 6.0 hil/u1 HEMOGLOBIN 14.7 3.3.2 - 18.0 FAH HEMATOCRIT 44.9 38.5 - 54.0 MCV 87 80.0 - 100.0 MCH 28.4 26.0 - 34.0 PS MCHC 32.8 31.0 - 37.0 gMl RDW 13.8 11.0 - 15.5 PLATELET COUNT 259 140 - 400 Wul MPV 9.3 7.5 - 11.6 11 DIFFERENTIAL GR% 37.0 L 38 - 75 LY% 41.8 15 - 49 MO% 11.1 2.0 - 13.0 FO% 8.6 0 - HA% 1.5 0 - 2 GR# 1.2 L 1.6 - 8.4 Kful LY# 1.3 1.0 - 3.6 Khl MO# 0.3 0.0 - 0.9 KM1 EON 0.3 0.0 - 0.6 1C/u1 BA# 0.0 0.0 - 0.2 Vol Smear review agrees with automated differential. HEMATOLOGY TESTS Sedimentation Rat!:, 25 H 0 - 20 mm/hr GENERAL CHEMISTRY GLUCOSE 107 H 65 - 100 mgidl BUN 26 H 6 - 20 mg/dl CREATININE, SERUM 1.0 0.5 - 1.2 mg/dl URIC ACID 6.3 3.4 - 7.0 mg/dl SODIUM 139 133 - 145 mmoLL POTASSIUM 4.5 3.3 - 5.1 Inmuld CHLORIDE 101 96 - 108 mmoht CO2 22 22 - 32 mmol;L CALCIUM 9.8 8.5 - 10.5 tug/di (Continued on Nat Page) EFTA01108077 go : rgilltbICAL LACIORATORIE 5151(238PCHIATEHLAY JUPITER. FL33458-310I (866)7204386 Client BRUCE MOSKOWITZ, M.D. 1411 N. FLAGLER DR. SUITE 7100 WEST PALM BEACH, FL 33401 Phys: MOSKOWITZ, BRUCE 2622 Patient: EPSTEKJEFFREY Room# Phone: 11)#: 262219530120h4IE Routo#: 0 DOB. 01/20/1953 Agc:63 Sex:M Fasting: N Pagc:2 Aceti 001081881 Chart# 19530120MJE First reported on: Coll. Date: 03/28/16 Coll. Time: 00:00 AM 03/28/16 Recv. Date: 03/28/16 Print Date: 03/30/16 Recv. Time:16:54:03 Print Time: 07:40 Final report date: 03/29/16 ' Test Name Results Normal Range I Units GENERAL CHEMISTRY (Continued) TOTAL PROTEIN 6.9 6.4 - 8.3 ALBUMIN 4.3 3.2 - 4.8 Wdl GLOBULIN 2 . 6 2.1 - 3.6 g/dl BILTRUBIN, TOTAL 0 . 6 0.0 • 1.0 rn/dl ALKALINE PHOSPHATASE 57 35 - 129 ALT 25 <42 U/L AST 19 <39 U/L Allaunin/Globulin Ratio 1.7 0.8 - 2.0 BUN/CREAT RATIO 26.0 H 7.3 - 21.7 GFR, estimated 80 mAtmin If African-American result is: >60 Calculation *Stage* Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 DIABETES EVALUATION HEMOGLOBIN A1C of estimated GFR is based on the MDRD Study prediction aquatic'', ****Five Stages of Chronic Kidney Disease**** *OFR Level* *Description* 90 ml/min or more Healthy Kidneys or Kidney 60 to 89 ml/min 30 to 59 ml/min 15 to 29 ml/min < 15 ml/min 5 . 6 damage with normal or high GFR Kidney damage and mild decrers in OFR Moderate decrease in OFR Severe decrease in OFR Kidney failure, or on dialysis < 5.7 95 ***Diagnosis*** Normal Prediabeteu Diabetes Having prediabetes is a Risk Factor for getting type prediabetes range(5.7-6.4), the higher the HbA1c,the diabetes. HbA1c target for diabetics depend on their IRON/ANEMIA EVALUATION : \MIN HI"' 405 CORONARY RISK TRIGLYCERIDES 712 H CHOLESTEROL, TOTAL 206 H (Continued on Next Page) ***HhAlc Level*** < 5.7 * 5.7 - 6.4 t or > 6.5 t 2 diabetes. Within the greater the risk of history and health. 243 - 894 Peng <150 mg/dl <200 tngidi EFTA01108078 frakAcres IEDICAL LASCIFIATORICEI 5151 CORPORATE WAY JUPITER, fl. 33458-3101 (4661120-8386 Client: BRUCE MOSKOWITZ., M.D. 1411 N. FLAGLER DR. SUITE 7100 WEST PALM BEACH, FL 33401 Phys: MOSKOWITZ, BRUCE 2622 Patient: EPSTEIN, JEFFREY Rowe Phone: ID#: 262219530120MJE Route#: 0 DOB. 01/20/1953 Agc:63 Scx:M Fasting: N Page3 Acdt 001081881 Chant/ 19530120MJE First reported on: Test Name Coll. Date: 03/28/16 Coll. Time: 00:00 AM 03/28/16 Rees. Date: 03/28/16 Print Date: 03130/16 Recv. Time:16:54:03 Print Time: 07:40 Final report date: 03/29/16 Results Normal Range I Units CORONARY RISK (Continued) IIDL CHOLESTEROL CHOL/HDL RATIO CRP, Cardio HOMOCYSTEINE THYROID TESTING T-Uptake T4, FREE TSH TUMOR MARKERS PSA, TOTAL ENDOCRINE EVALUATION PROLACTIN TESTOSTERONE, TOTAL Parathyroid Hormone, Intact Low Risk Medium Risk High Risk 16.2 H 1.03 1.10 1.800 0.595 4.2 105 L 63.1 23 L 9.0 H >40 mg/d1 <5.0 The higher the Ratio,the higher CND risk. 1 . 7 <3.0 mg/L. **Risk of Cardiovasular Disease** CRP < 1.0 CRP 1.0 - 3.0 CRP > 3.0 mg/L mg/L mg/L 4.5 - 15.0 ummUL Ideal level <8.0 umo1/1, 0.8 - 1.3 0.9 - 1.7 0.27 - 4.2 TBI ng/dl ulUhnl 0.0 - 4.0 nerM 4.1 - 18.4 280 - 1100 15 - 65 OTHER TESTS VITAMIN D,25-HYDROXY Vitamin D,25-011,Total 40 >30 nghral Rotes: Therapy is based on the measurement of Total Vitamin D (25-OH). Most experts agree that Vitamin D deficiency should be = or < 20 ng/ml. Vitamin D insufficiency is recognized as 21 - 29 ng/ml. The prefered level for Vitamin D (25-OH)is recommended to be = or >30 nghoil (Continued on Next Page) EFTA01108079 140Appeisa 5151 CORPORATE WAY JUPITER, FL 33458-3101 (866)7204386 Client: BRUCE MOSKOWITZ, M.D. 1411 N. FLAGLER DR. SUITE 7100 WEST PALM BEACH, FL 33401 Phys: MOSKOWITZ, BRUCE 2622 Patient: EPSTEIN, JEFFREY Room# DOB. 01/20/1953 Age:63 Sex:M Phone: Fasting: N ID#: 262219530120MJE Route#: 0 Page:4 Acc# 001081881 Chart# 19530120MJE First reported on: Coil. Date: 03/28/16 Coll. Time: 00:00 AM 03/28/16 Recv. Date: 03/28/16 Print Date: 03/30/16 Recv. Time:16:54:03 Print Time: 07:40 Final report date: 03/29/16 Test Name Results I Normal Range Units SEROLOGY CRP, inflammation 1.7 B.0 . END OF REPORT EFTA01108080